Boltežar L et al.Comparison of the algorithms classifying the ABC and GCB subtypes in diffuse large B-cell lymphoma.Oncol Lett 15:6903-6912 (2018).
Lu TX et al.Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.Sci Rep 5:12168 (2015).
Tzankov A et al.Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study.J Hematol Oncol 8:70 (2015).
Xie Y et al.p53 expression is a strong marker of inferior survival in de novo diffuse large B-cell lymphoma and may have enhanced negative effect with MYC coexpression: a single institutional clinicopathologic study.Am J Clin Pathol 141:593-604 (2014).
Tan LH & Tan SY Aberrant immunoarchitecture distinguishes hyperplastic germinal centres in pattern 1 angioimmunoblastic T-cell lymphoma from reactive follicles.Hematol Oncol 32:145-54 (2014).
Rossi D et al.Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis.Int J Cancer 130:3006-10 (2012).
Sebestyén A et al.Activity and complexes of mTOR in diffuse large B-cell lymphomas-a tissue microarray study.Mod Pathol : (2012).
Montes-Moreno S et al.Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas.Blood 111:351-8 (2008).